期刊文献+

细胞因子与基因治疗股骨头缺血性坏死的研究动态 被引量:1

Research trends of cytokines and gene therapy for treating avascular necrosis of the femoral head
在线阅读 下载PDF
导出
摘要 股骨头缺血性坏死是由多种病因造成的股骨头缺血和骨细胞坏死的病理过程,是骨科难治疾病之一。近年来细胞因子与基因治疗作为新近发展起来的一项新技术在股骨头坏死的研究中应用颇多。多种细胞因子及其转导入种子细胞的基因可以不同程度促进血管重建与骨修复,从而恢复股骨头血供及修复骨坏死。目前的研究还多处于实验阶段,如何延长转入基因表达时间,如何选择一种低毒、低免疫反应载体与支架材料的选择等问题将成为以后研究的重点。 The treatment of avascular necrosis of the femoral head whose pathological procedure is femoral head avascularity and osteocyte necrosis induced by many etiological factors is one of the difficult subjects in orthopaedics. As a newly-developed technology, cytokines and gene therapy have been widely used in the research of avascular necrosis of the femoral head. Many cytokines and transduced genes have the effects of promoting vascular reconstruction and bone repairment so that it could recover the blood supply and repair the osteonecrosis of femoral heads. Most current researches remain in the experimental phase. Therefore, the research focus in the future comes down to the lengthening of gene transfection expression as well as the selection of vectors and tissue engineering bones that have low immunereaction and low toxicity.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第41期8135-8138,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献8

二级参考文献66

  • 1曾春,蔡道章,全大萍,布丽斯,卢华定,李晓峰,史德海.TGF-β1壳聚糖缓释微球的制备和体外检测[J].中山大学学报(医学科学版),2005,26(3):347-350. 被引量:18
  • 2曾春,蔡道章,全大萍,廖凯荣,卢华定,李晓峰,史德海.TGF-β1缓释载体体外构建组织工程软骨[J].中华显微外科杂志,2005,28(4):324-327. 被引量:12
  • 3CAI Dao-zhang,ZENG Chun,QUAN Da-ping,BU Li-si,WANG Kun,LU Hua-ding,LI Xiao-feng.Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-β_1 delivery for cartilage tissue engineering[J].Chinese Medical Journal,2007(3):197-203. 被引量:20
  • 4Lieberman JR, Le LQ, Wu L,et al. Regional gene therapy with a BMpo2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents[ J]. J Orthop Res, 1998,16(3) :330 -339.
  • 5Robbins PD, Ghivizzani SC. Viral vectors for gene therapy[ J]. Pharmacol Ther,1998,80( 1 ) :35 -47.
  • 6Lieberman JR, Le LQ, Wu L, et al. Regional gene therapy with a BMP-2 producing stromal cell line induces heterotopic and orthotopic bone formation in rodents[ J ]. J Orthop Res, 1998,16 ( 3 ) : 330 - 339.
  • 7Breitbart AS,Gfande DA, Mason JM, et al. Gene enhanced tissue engineering: application for bone healing using cultured periosteal cells transduced retrovirually with the BMP7 gene [ J ]. Ann Plast Surg, 1999,42 ( 50 ) :488 - 495.
  • 8Engstrand T, Daluiski A, Bahamonde ME,et al. Transient production of bone morphogenetic protein-2 by allogeneic transplanted transduced cells induces bone formation [ J ]. Hum Gene Ther, 2000,11 (1) :205 -211.
  • 9Alden TD, Pittman DD, Hankins GR, et al. In vivo endochondral bone formation using a bone morphogenetic protein-2 adenoviral vector[ J]. Hum Gene Ther, 1999,10( 13 ) :2245 - 2253.
  • 10Khouri RK, Brown DM, Koudsi B, et al. Repair of ealvarial defects wiry flap tissue: role of bone morphogenetie proteins and eompetent responding tissues [ J ]. Plast Reeonstr Surg, 1996, 98: (1) 103 - 109.

共引文献78

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部